Intraperitoneal chemotherapy for ovarian cancer: A complex strategy but what an exciting avenue!;La chimiothérapie intrapéritonéale pour traiter le cancer de l'ovaire: Une stratégie complexe, mais une option captivante!

Bulletin du Cancer

Volumn 93, Issue 9, 2006, Pages 959-960

  Provencher, Diane M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BLEEDING; CANCER CHEMOTHERAPY; COMORBIDITY; FEMALE; HUMAN; INTESTINE PERFORATION; OVARY CANCER; SHORT SURVEY; ARTICLE; CANADA; CLINICAL TRIAL; INFUSION; MEDICAL SOCIETY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; ONCOLOGY; OVARY TUMOR;

CANADA; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MEDICAL ONCOLOGY; OVARIAN NEOPLASMS; SOCIETIES, MEDICAL;

EID: 33749044446     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996; 335: 1950-5.
2. Markman M, Bundy BN, Alberts DS, Fowler JM, Clark-Pearson DL, Carson LF, et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001; 19: 1001-7.
3. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 34-43.
4. Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Berger RA, et al. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Gynecol Oncol 2006; 100: 27-32.